Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Huifeng Bio-Technic Raises Money for New Production Facility

publication date: Nov 11, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Huifeng Bio-Pharmaceutical Technology raised $3.9 million in financing for a new Diosmin processing plant. Diosmin is a TCM nutritional supplement given to treat chronic venous insufficiency and hemorrhoids. The new facility will have the capacity to produce 500 tons of Diosmin each year, raising the company’s capacity to 600 tons, and generating up to $20 million in revenue annually. More details....

Stock Symbol: (OTCBB: HFGB)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...